Fenoldopam indications and usage

Revision as of 03:08, 27 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Fenoldopam}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== Adult Patients: Fenoldopam is indicated for the in-hospital, short-term (up to 48 hours) management...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Fenoldopam
CORLOPAM® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Fenoldopam
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Indications and Usage

Adult Patients: Fenoldopam is indicated for the in-hospital, short-term (up to 48 hours) management of severe hypertensionwhen rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertensionwith deteriorating end-organ function. Transition to oral therapy with another agent can begin at any time after blood pressure is stable during fenoldopam infusion.

Pediatric Patients: Fenoldopam is indicated for the in-hospital, short-term (up to 4 hours) reduction in blood pressure (See CLINICAL PHARMACOLOGY/Pediatric Patients).[1]

References

  1. "CORLOPAM (FENOLDOPAM MESYLATE) INJECTION, SOLUTION [HOSPIRA, INC.]". Retrieved 26 February 2014.

Template:Sympatholytic antihypertensives